Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn crawled time : 12:30 save search
Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2024-02-05 (Crawled : 12:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.17%
H: 0.09%
C: -2.76%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 33.84%
H: 1.01%
C: -15.3%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.76%
H: 0.77%
C: 0.0%
reqorsa first lung cancer treat cell expansion therapy study
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
Published: 2023-12-19 (Crawled : 12:30) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 178.08%
H: 21.18%
C: -1.48%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.5%
H: 0.99%
C: 0.43%
first payment astrazeneca cancer trial milestone
Pulmonary Drug Delivery Systems Global Market Forecasts to 2026: Focus on Metered-dose Inhalers, Dry Powered Inhalers, Soft Mist Inhalers and Nebulizers
Published: 2022-01-21 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.43%
H: 0.0%
C: -2.91%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
drug liver system drug delivery
Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics
Published: 2022-01-05 (Crawled : 12:30) - prnewswire.com
CNTX | $1.39 -1.42% -1.44% 5.7K
|
Health Technology
|
| O: -1.46%
H: 3.33%
C: -7.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
partnership therapeutics molecular antibody platform
GERD Market Size to grow by USD 793.85 Mn | North America to emerge as largest market | Technavio
Published: 2021-11-24 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.8%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.02%
H: 1.33%
C: 1.33%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.85%
H: 0.07%
C: -0.17%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
merge
Generic Injectable Market to Top US$ 85 Bn by 2031, Growing Burden of Lifestyle Diseases to Accelerate the Sales: FMI
Published: 2021-11-24 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.02%
H: 1.33%
C: 1.33%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: 0.11%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.19%
H: 0.83%
C: -0.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
disease sales growing
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.